“It’s not enough to pull drowning victims out of the river. You have to walk upstream to find out who’s throwing them in.” Physician and educator David Kilgore invoked that piece of wisdom from Episcopal bishop V. Gene Robinson to describe the current state of medicine in the United States — and the steps needed to drag the nation’s outmoded, costly and inefficient healthcare system into the 21st century.
McKesson Specialty Health has announced the integration of its distribution services with General Medical Services’ Physician Office Drug Inventory System, an alliance that creates the first end-to-end integrated inventory and order-to-reimbursement verification solution designed specifically for ophthalmologists.
Many parents with established relationships with pediatricians are turning to retail-based health clinics when their children suffer from minor ailments largely because of convenience, according to research published this week in JAMA Pediatrics.
Swiss Precision Diagnostics unveiled the new Clearblue Advanced Pregnancy Test with Weeks Estimator at the 61st Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists here.
NeoStrata, the creator of the original lunchtime glycolic acid peel, has unveiled its new Exuviance Age Reverse HydraFirm, which targets all visible signs of aging and rehydrates the skin at deep levels so skin looks and feels younger.
Who needs the services of community pharmacists and the nurse practitioners who staff retail-based walk-in clinics and ambulatory care centers? Among others, the nearly 67 million Americans underserved by primary care physicians.
A 30% rise in attendance at the Armada Specialty Pharmacy Summit is nothing to brush off — it's as clear an indication as any that specialty pharmacy is growing and probably poised for more growth in the near future, thanks in particular to the aging population and consequential rise in the number of people living with difficult-to-treat medical conditions.
Walgreens Specialty Pharmacy on Thursday added six medications to its oral oncology cycle management program, in a significant expansion of the comprehensive treatment and support program it provides to benefit patients, physicians and payers, the company announced.